✦ LIBER ✦

Focus groups in the virtual world: Implications for the future of evaluation

✍ Scribed by Kristin L. Galloway

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 2011
Category: Article
ISSN: 1097-6736
DOI: 10.1002/ev.377

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The future of reference and information

The future of reference and information services in a virtual world

✍ Denise Agosto; Eileen Abels; Lily Rozaklis; Craig MacDonald 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 34 KB

## Introduction, Background, and Research Questions Over the past few years, reference and information services have increasingly moved away from library reference desks and away from libraries' print collections out into the virtual world. A number of studies have examined virtual reference servi

In focus: the future of sustainable mate

In focus: the future of sustainable materials for industry

✍ Peter J Lillford 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

The use of focus groups as a tool for CM

The use of focus groups as a tool for CME program evaluation

✍ Jane Tipping; Jerry Tennenbaum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Leaders and their treatment of subgroups

Leaders and their treatment of subgroups: implications for evaluations of the leader and the superordinate group

✍ Julie M. Duck; Kelly S. Fielding 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

The long-term development of fighting in

The long-term development of fighting in mice: Implications for future research

✍ Dr. Morris K. Morgret 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

The financial burden of malaria in Tanza

The financial burden of malaria in Tanzania: implications for future government policy

✍ Matthew Jowett; Nigel J. Miller 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Malaria is the cause of more mortality and morbidity in Tanzania than any other disease, in large part due to growing resistance to anti-malarial drugs. This study estimates that over 1% of GDP is devoted to the disease, representing US$2.2 per capita, and 39% of total health expenditure nationally.